mind medicine mindmed glp-1 receptor agonist medications The Impact of Agonists (GLP-1 RAs) on Mental Health: A Systematic Review | Current Treatment Options in Psychiatry GLP-1s Like Ozempic May Be

Rates of nonfatal myocardial infarction and nonfatal stroke were lower in the liraglutide group than in the placebo group, but these differences were not statistically significant

Does the GLP-1 Mechanism Actually Work

However, she called the osteoporosis finding an early signal, noting that I dont think its conclusive. Future research on GLP-1 medications should focus on the incidence of fractures, which bone density loss can increase risk of, she said

95% CI, 0.511.08)

Key Development: February 2026: The Phase 3 TRIUMPH-1 trial results for orforglipron showed a mean body weight reduction of 14.7% at 36 weeks in adults with obesity without diabetes, according to Eli Lilly and Company

doi: 10.1210/jc.2016-3285 24 WalzerDTurcuAFJhaSAbelBSAuchusRJMerkeDPet al